Therapeutic drug monitoring of oral anticancer drugs - preliminary results of a prospective study

被引：0
|
作者：
Groenland, S. L. [1 ]
Van Eerden, R. A. G. [2 ]
Koolen, S. L. [3 ]
Moes, D. J. A. R. [4 ]
Desar, I. M. E. [5 ]
Touw, D. J. [6 ]
Imholz, A. L. T. [7 ]
Reyners, A. K. L. [8 ]
Gelderblom, H. [9 ]
van Erp, N. P. [10 ]
Mathijssen, R. H. J. [2 ]
Huitema, A. D. R. [11 ]
Steeghs, N. [1 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Med Oncol & Clin Pharmacol, Amsterdam, Netherlands
[2] Erasmus MC, Med Oncol, Inst Canc, Rotterdam, Netherlands
[3] Erasmus MC, Med Oncol & Hosp Pharm, Rotterdam, Netherlands
[4] Leiden Univ, Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Oncol, Med Ctr, Nijmegen, Netherlands
[6] Univ Med Ctr Groningen, Clin Pharm & Pharmacol, Groningen, Netherlands
[7] Ziekenhuis Deventer, Internal Med, Deventer, Netherlands
[8] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands
[9] Leiden Univ, Med Oncol, Med Ctr, Leiden, Netherlands
[10] Radboud Univ Nijmegen, Pharmacol, Med Ctr, Nijmegen, Netherlands
[11] Antoni van Leeuwenhoek Hosp, Pharm & Pharmacol, Netherlands Canc Inst, Amsterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
442O
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study
    Groenland, Stefanie L.
    van Eerden, Ruben A. G.
    Verheijen, Remy B.
    Koolen, Stijn L. W.
    Moes, Dirk Jan A. R.
    Desar, Ingrid M. E.
    Reyners, Anna K. L.
    Gelderblom, Hans J.
    van Erp, Nielka P.
    Mathijssen, Ron H. J.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    THERAPEUTIC DRUG MONITORING, 2019, 41 (05) : 561 - 567
  • [2] Therapeutic drug monitoring for oral anticancer drugs in clinical routine: The ON-TARGET study
    Mc Laughlin, A.
    Schmulenson, E.
    Teplytska, O.
    Zimmermann, S.
    Opitz, P.
    Groenland, S. L.
    Huitema, A.
    Steeghs, N.
    Mueller, L.
    Fuxius, S.
    Joerger, M.
    Mayer, F.
    Fuhr, U.
    Holdenrieder, S.
    Hempel, G.
    Scherf-Clavel, O.
    Mikus, G.
    Jaehde, U.
    Kloft, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 50 - 50
  • [3] Rationale for therapeutic drug monitoring (TDM) of anticancer drugs
    Boddy, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 8 - 8
  • [4] Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol
    Mc Laughlin, Anna M.
    Schmulenson, Eduard
    Teplytska, Olga
    Zimmermann, Sebastian
    Opitz, Patrick
    Groenland, Stefanie L.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    Mueller, Lothar
    Fuxius, Stefan
    Illerhaus, Gerald
    Joerger, Markus
    Mayer, Frank
    Fuhr, Uwe
    Holdenrieder, Stefan
    Hempel, Georg
    Scherf-Clavel, Oliver
    Jaehde, Ulrich
    Kloft, Charlotte
    CANCERS, 2021, 13 (24)
  • [5] Therapeutic drug monitoring of oral targeted antineoplastic drugs
    Anna Mueller-Schoell
    Stefanie L. Groenland
    Oliver Scherf-Clavel
    Madelé van Dyk
    Wilhelm Huisinga
    Robin Michelet
    Ulrich Jaehde
    Neeltje Steeghs
    Alwin D.R. Huitema
    Charlotte Kloft
    European Journal of Clinical Pharmacology, 2021, 77 : 441 - 464
  • [6] Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs
    Janssen, Julie M.
    Dorlo, Thomas P. C.
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    THERAPEUTIC DRUG MONITORING, 2020, 42 (04) : 532 - 539
  • [7] Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs
    Rousseau, A
    Marquet, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (04) : 253 - 262
  • [8] Therapeutic drug monitoring of non-anticancer drugs in cancer patients
    Joerger, M
    Schellens, JHM
    Beijnen, JH
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2004, 26 (07): : 531 - 545
  • [9] Review of therapeutic drug monitoring of anticancer drugs part 1-Cytotoxics
    Paci, Angelo
    Veal, Gareth
    Bardin, Christophe
    Leveque, Dominique
    Widmer, Nicolas
    Beijnen, Jos
    Astier, Alain
    Chatelut, Etienne
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (12) : 2010 - 2019
  • [10] Review of therapeutic drug monitoring of anticancer drugs part two - Targeted therapies
    Widmer, Nicolas
    Bardin, Christophe
    Chatelut, Etienne
    Paci, Angelo
    Beijnen, Jos
    Leveque, Dominique
    Veal, Gareth
    Astier, Alain
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (12) : 2020 - 2036
12345